Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bone Neoplasms × Diathermy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hyperthermia 16 Sarcoma 7 Uterine Cervical Neoplasms 5 Prostatic Neoplasms 5 Breast Neoplasms 5 Rectal Neoplasms 4 Neoplasm Metastasis 4 Colonic Neoplasms 4 Ovarian Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Sarcoma, Synovial 2 Neurofibrosarcoma 2 Neoplasms 2 Lung Neoplasms 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Fibrosarcoma 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Adenoma, Pleomorphic 1 Rhabdomyosarcoma 1

Interventions

Ibandronic Acid 8 Gemcitabine 7 Doxorubicin 6 Cyclophosphamide 5 Radiation 4 Nivolumab 4 Irinotecan 4 pembrolizumab 3 Zoledronic Acid 3 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Methotrexate 2 Injections 2 Ifosfamide 2 Etoposide 2 Denosumab 2 Cryotherapy 2 Cryosurgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡